Thus, the aim of this study is to collect and analyze the clinicopathologic features, diagnosis, and treatment outcomes of patients by constructing a multicenter registry of patients with EGFR‐mutated NSCLC. This evidence concerns the gene EGFR and non-small cell lung carcinoma.